# ME-3 Qualified-Human Citation Verification — Proposed Review

- Baseline: `4d7a60ac4cc7de8d2d91f46210f64fa15f54abd4`
- Status: **APPROVED-AND-APPLIED-LOCALLY — 5/5 VERIFIED**
- Rows reviewed: **5**
- Approve as implemented: **5**
- Approve with narrowing: **0**
- Replace source: **0**
- Reject/withdraw: **0**
- Unresolved: **0**

All five KB references remain `verified:false`; all five master-source entities remain `pending-verification` until explicit approval.

## Row dispositions

### 1. `acromegaly -> sleep-apnea`
- PMID **31722411** — DOI `10.1210/clinem/dgz116`
- Source: *Obstructive Sleep Apnea in Acromegaly and the Effect of Treatment: A Systematic Review and Meta-Analysis*
- Decision: **approve-as-implemented**
- Evidence fit: Directly evaluates obstructive sleep apnea in acromegaly, including OSA prevalence/AHI and longitudinal pre/post-treatment AHI. The implemented guard already limits the broad sleep-apnea taxonomy target to OSA, requires separately established OSA, and prohibits automatic individual causation.
- Limitation/guard check: Active versus inactive acromegaly did not show a significant cross-sectional difference in OSA prevalence or AHI; the strongest longitudinal finding is improvement in AHI after acromegaly treatment. Therefore the source supports a bounded comorbidity/association and treatment-response proposition, not automatic individual causation.

### 2. `ankylosing-spondylitis -> uveitis`
- PMID **23999006** — DOI `10.1136/annrheumdis-2013-203582`
- Source: *Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis*
- Decision: **approve-as-implemented**
- Evidence fit: Directly supports uveitis as a common extra-articular manifestation in ankylosing spondylitis and reports a pooled uveitis prevalence of 25.8%. The implemented guard requires ophthalmic diagnosis and preserves alternative causes.
- Limitation/guard check: This is prevalence/association evidence with substantial heterogeneity across studies; it does not establish individual causation.

### 3. `hyperparathyroidism -> osteoporosis`
- PMID **41329412** — DOI `10.1007/s00508-025-02670-z`
- Source: *Bone metabolism in primary hyperparathyroidism*
- Decision: **approve-as-implemented**
- Evidence fit: Directly addresses primary hyperparathyroidism skeletal disease: increased bone remodeling/resorption, declining BMD, compromised bone quality, increased fracture risk, and reported osteoporosis in PHPT cohorts. The implemented guard restricts the relationship to primary hyperparathyroidism and requires separately established osteoporosis.
- Limitation/guard check: The article is a review rather than a dedicated systematic review of osteoporosis incidence. Existing phenotype and diagnostic guards are therefore important and sufficient; no further narrowing is required.

### 4. `cushings-syndrome -> osteoporosis`
- PMID **39689783** — DOI `10.1016/j.eprac.2024.12.009`
- Source: *Bone Mineral Density Improvement After Resolution of Endogenous Cushing Syndrome: A Systematic Review and Meta-Analysis*
- Decision: **approve-as-implemented**
- Evidence fit: Directly restricted to endogenous Cushing syndrome and demonstrates significant lumbar-spine and femoral-neck BMD improvement after resolution. The paper frames the findings as relevant to endogenous-Cushing-associated osteoporosis. This precisely matches the implemented endogenous-Cushing restriction.
- Limitation/guard check: The meta-analysis evaluates BMD change after disease resolution; sample size was 302 across 12 studies and lumbar-spine estimates showed substantial heterogeneity. The implemented guard already requires separately established osteoporosis and excludes exogenous glucocorticoid-only disease.

### 5. `hyperthyroidism -> cardiac-arrhythmia`
- PMID **38377675** — DOI `10.1530/ETJ-23-0254`
- Source: *Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation*
- Decision: **approve-as-implemented**
- Evidence fit: Directly states that atrial fibrillation is the most common cardiac complication of hyperthyroidism, occurring in 5-15% of overtly hyperthyroid patients, and describes frequent spontaneous reversion after restoration of euthyroidism. The implemented guard limits the broad cardiac-arrhythmia target to documented atrial fibrillation.
- Limitation/guard check: The source is AF-specific and does not support generalization to all arrhythmias. The existing AF-only guard fully addresses that limitation.

## Recommended approval scope

Approve all five ME-3 citations as implemented. After explicit approval, a separate local-only verification runner may atomically promote the five KB references from verified:false to verified:true and the five master sources from pending-verification to active, with no relationship, direction, guard, PMID, DOI, taxonomy, publication-status, or pathwayIntelligence changes.


## Qualified-human approval

Approved on **2026-08-20** against exact ME-3 implementation baseline:

`4d7a60ac4cc7de8d2d91f46210f64fa15f54abd4`

Approved dispositions:
- 5 approve as implemented
- 0 approve with narrowing
- 0 replacements
- 0 rejects/withdrawals

Authorized state transition only:
- five KB references: `verified:false -> verified:true`
- five master sources: `pending-verification -> active`

No relationship entity, rationale, publication guard, PMID, DOI, citation text, source URL, rank, prevalence, taxonomy, publication status, or `pathwayIntelligence` change is authorized.

Top-level master-registry baseline/current-state metadata may advance to this closed ME-3 implementation baseline; relationship records themselves remain unchanged.

Intended local commit:

`verify: mapping expansion ME-3 citations (5 relationships)`

## Local verification result

- 5/5 KB references promoted to `verified:true`.
- 5/5 master sources promoted to `active`.
- No relationship entity, guard, source identity, taxonomy, publication status, or pathwayIntelligence change.
- No remote writes.
